FdaApplication
ANDA 220335
Identifiers
- fda_app_no: ANDA220335
Properties
| Property | Value |
|---|---|
| applicant_name | RUBICON RESEARCH LTD |
| application_type | ANDA |
| approval_date | 2026-02-25 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CETIRIZINE HYDROCHLORIDE | CETIRIZINE HYDROCHLORIDE | 5MG/5ML | SOLUTION;ORAL |
1 product